A Study of Amygdala Retraining Program in Patients with Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia

Overview

About this study

The purpose of this study is to gather preliminary data on the effectiveness and feasibility of the Amygdala Retraining Program, a mind-body practice, on fatigue, quality of life and sleep in patients with Chronic Fatigue Syndrome, Chronic Fatigue, and Fibromyalgia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Meets CDC criteria for Chronic Fatigue Syndrome, has been diagnosed with chronic fatigue, or meets the American College of Rheumatology criteria for fibromyalgia

Exclusion Criteria

Untreated hypo or hyper thyroidism
Untreated hypo or hyper parathyroidism
Untreated adrenal disorders
Untreated diabetes
Multiple sclerosis
Acute or chronic hepatitis
History of cancer
Untreated depression
Chronic steroid use
Acute inflammatory rheumatological conditions
Untreated obstructive sleep apnea
Narcolepsy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Ann Vincent, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Ann Vincent, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials